Bacterial responses to antibiotics and their combinations

Environmental Microbiology Reports

Volumn 6, Issue 6, 2014, Pages 545-557

  Mitosch, Karin ^a   Bollenbach, Tobias ^a  

^a INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

BACTERIUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL;

EID: 84913591984     PISSN: None     EISSN: 17582229     Source Type: Journal    
DOI: 10.1111/1758-2229.12190     Document Type: Review

References (134)

1. Allison, K.R., Brynildsen, M.P., and Collins, J.J. (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220.
2. Andersson, D.I., and Hughes, D. (2014) Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12: 465-478.
3. Andrews, J.M. (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48: 5-16.
4. Ankomah, P., and Levin, B.R. (2012) Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. PLoS Pathog 8: e1002487.
5. Aumercier, M., Murray, D.M., and Rosner, J.L. (1990) Potentiation of susceptibility to aminoglycosides by salicylate in Escherichia coli. Antimicrob Agents Chemother 34: 786-791.
6. Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., etal. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006.0008.
7. Balaban, N.Q., Merrin, J., Chait, R., Kowalik, L., and Leibler, S. (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622-1625.
8. Ball, P. (2007) Conclusions: the future of antimicrobial therapy - Augmentin® and beyond. Int J Antimicrob Agents 30 (Suppl. 2): 139-141.
9. Baquero, F., and Negri, M.C. (1997) Challenges: selective compartments for resistant microorganisms in antibiotic gradients. Bioessays 19: 731-736.
10. Bayer, A.S., and Morrison, J.O. (1984) Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob Agents Chemother 26: 220-223.
11. Berthoumieux, S., de Jong, H., Baptist, G., Pinel, C., Ranquet, C., Ropers, D., and Geiselmann, J. (2013) Shared control of gene expression in bacteria by transcription factors and global physiology of the cell. Mol Syst Biol 9: 634.
12. Bliss, C.I. (1939) The toxicity of poisons applied jointly. Ann Appl Biol 26: 585-615.
13. Bollenbach, T., and Kishony, R. (2011) Resolution of gene regulatory conflicts caused by combinations of antibiotics. Mol Cell 42: 413-425.
14. Bollenbach, T., Quan, S., Chait, R., and Kishony, R. (2009) Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139: 707-718.
15. Bremer, H., and Dennis, P.P. (2008) Modulation of chemical composition and other parameters of the cell at different exponential growth rates. EcoSal Plus 2008. doi:10.1128/ecosal.5.2.3.
16. Bremer, H., Dennis, P., and Ehrenberg, M. (2003) Free RNA polymerase and modeling global transcription in Escherichia coli. Biochimie 85: 597-609.
17. Brochado, A.R., and Typas, A. (2013) High-throughput approaches to understanding gene function and mapping network architecture in bacteria. Curr Opin Microbiol 16: 199-206.
18. Brown, M.R., Collier, P.J., and Gilbert, P. (1990) Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 34: 1623-1628.
19. Burns, J.L., and Clark, D.K. (1992) Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother 36: 2280-2285.
20. Caminero, J.A., Sotgiu, G., Zumla, A., and Migliori, G.B. (2010) Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. Lancet Infect Dis 10: 621-629.
21. Chait, R., Craney, A., and Kishony, R. (2007) Antibiotic interactions that select against resistance. Nature 446: 668-671.
22. Chan, E.L., and Zabransky, R.J. (1987) Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of pseudomonas. Diagn Microbiol Infect Dis 6: 157-164.
23. Chopra, I., and Linton, A. (1986) The antibacterial effects of low concentrations of antibiotics. In Advances in Microbial Physiology, Vol. 28. Rose, A.H., and Tempest, D.W. (eds). London, UK: Academic Press, pp. 212-259.
24. Cokol, M., Chua, H.N., Tasan, M., Mutlu, B., Weinstein, Z.B., Suzuki, Y., etal. (2011) Systematic exploration of synergistic drug pairs. Mol Syst Biol 7: 544.
25. Cokol, M., Weinstein, Z.B., Yilancioglu, K., Tasan, M., Doak, A., Cansever, D., etal. (2014) Large-scale identification and analysis of suppressive drug interactions. Chem Biol 21: 541-551.
26. Costerton, J.W., and Cheng, K.J. (1975) The role of the bacterial cell envelope in antibiotic resistance. J Antimicrob Chemother 1: 363-377.
27. Cottarel, G., and Wierzbowski, J. (2007) Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol 25: 547-555.
28. Dalebroux, Z.D., and Swanson, M.S. (2012) ppGpp: magic beyond RNA polymerase. Nat Rev Microbiol 10: 203-212.
29. Dantas, G., Sommer, M.O.A., Oluwasegun, R.D., and Church, G.M. (2008) Bacteria subsisting on antibiotics. Science 320: 100-103.
30. Datsenko, K.A., and Wanner, B.L. (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
31. Davies, J., Spiegelman, G.B., and Yim, G. (2006) The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 9: 445-453.
32. Davis, B.D. (1982) Bactericidal synergism between β-lactams and aminoglycosides: mechanism and possible therapeutic implications. Rev Infect Dis 4: 237-245.
33. Dekel, E., and Alon, U. (2005) Optimality and evolutionary tuning of the expression level of a protein. Nature 436: 588-592.
34. Deris, J.B., Kim, M., Zhang, Z., Okano, H., Hermsen, R., Groisman, A., and Hwa, T. (2013) The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria. Science 342: 1237435.
35. Dharmadi, Y., and Gonzalez, R. (2004) DNA microarrays: experimental issues, data analysis, and application to bacterial systems. Biotechnol Prog 20: 1309-1324.
36. Dwyer, D.J., Belenky, P.A., Yang, J.H., MacDonald, I.C., Martell, J.D., Takahashi, N., etal. (2014) Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci USA 111: E2100-2109.
37. Ejim, L., Farha, M.A., Falconer, S.B., Wildenhain, J., Coombes, B.K., Tyers, M., etal. (2011) Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol 7: 348-350.
38. Elf, J., Nilsson, K., Tenson, T., and Ehrenberg, M. (2006) Bistable bacterial growth rate in response to antibiotics with low membrane permeability. Phys Rev Lett 97: 258104.
39. Eliopoulos, G.M., and Eliopoulos, C.T. (1988) Antibiotic combinations: should they be tested? Clin Microbiol Rev 1: 139-156.
40. Elwell, L.P., Wilson, H.R., Knick, V.B., and Keith, B.R. (1986) In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 29: 1092-1094.
41. Esquerré, T., Laguerre, S., Turlan, C., Carpousis, A.J., Girbal, L., and Cocaign-Bousquet, M. (2013) Dual role of transcription and transcript stability in the regulation of gene expression in Escherichia coli cells cultured on glucose at different growth rates. Nucleic Acids Res 42: 2460-2472.
42. Essa, A.S., Kramer, J.R., Graham, D.Y., and Treiber, G. (2009) Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing 'concomitant therapy' versus triple therapy for Helicobacter pylori eradication. Helicobacter 14: 109-118.
43. Evans, D.J., Brown, M.R.W., Allison, D.G., and Gilbert, P. (1990) Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle. J Antimicrob Chemother 25: 585-591.
44. Falconer, S.B., Czarny, T.L., and Brown, E.D. (2011) Antibiotics as probes of biological complexity. Nat Chem Biol 7: 415-423.
45. Fernandes, P. (2006) Antibacterial discovery and development - the failure of success? Nat Biotechnol 24: 1497-1503.
46. Fraser, T.R. (1872) Lecture on the antagonism between the actions of active substances. Br Med J 2: 457-459.
47. Gama-Castro, S., Salgado, H., Peralta-Gil, M., Santos-Zavaleta, A., Muñiz-Rascado, L., Solano-Lira, H., etal. (2011) RegulonDB version 7.0: transcriptional regulation of Escherichia coli K-12 integrated within genetic sensory response units (Gensor Units). Nucleic Acids Res 39: D98-D105.
48. Gao, H., Granka, J.M., and Feldman, M.W. (2010) On the classification of epistatic interactions. Genetics 184: 827-837.
49. Gerosa, L., Kochanowski, K., Heinemann, M., and Sauer, U. (2013) Dissecting specific and global transcriptional regulation of bacterial gene expression. Mol Syst Biol 9: 658.
50. Geva-Zatorsky, N., Dekel, E., Cohen, A.A., Danon, T., Cohen, L., and Alon, U. (2010) Protein dynamics in drug combinations: a linear superposition of individual-drug responses. Cell 140: 643-651.
51. Goh, E.B., Yim, G., Tsui, W., McClure, J., Surette, M.G., and Davies, J. (2002) Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA 99: 17025-17030.
52. Goldoni, M., and Johansson, C. (2007) A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicol in Vitro 21: 759-769.
53. Greco, W.R., Bravo, G., and Parsons, J.C. (1995) The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47: 331-385.
54. Gruber, T.M., and Gross, C.A. (2003) Multiple sigma subunits and the partitioning of bacterial transcription space. Annu Rev Microbiol 57: 441-466.
55. Gupta, R.S. (2011) Origin of diderm (gram-negative) bacteria: antibiotic selection pressure rather than endosymbiosis likely led to the evolution of bacterial cells with two membranes. Antonie Van Leeuwenhoek 100: 171-182.
56. Harvey, R.J. (1973) Growth and initiation of protein synthesis in Escherichia coli in the presence of trimethoprim. J Bacteriol 114: 309-322.
57. Harvey, R.J. (1978) Interaction of two inhibitors which act on different enzymes of a metabolic pathway. J Theor Biol 74: 411-437.
58. Harvey, R.J., and Koch, A.L. (1980) How partially inhibitory concentrations of chloramphenicol affect the growth of Escherichia coli. Antimicrob Agents Chemother 18: 323-337.
59. Hayashi, Y., and Paterson, D.L. (2012) The epidemiology of pan/extreme drug resistance. In Antibiotic Policies. Gould, I.M., and van der Meer, J.W.M. (eds). New York, USA: Springer, pp. 27-38.
60. Hegreness, M., Shoresh, N., Damian, D., Hartl, D., and Kishony, R. (2008) Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci USA 105: 13977-13981.
61. Hitchings, G. (1971) Folate antagonists as antibacterial and antiprotozoal agents. Ann N Y Acad Sci 186: 444-451.
62. Hoffman, L.R., D'Argenio, D.A., MacCoss, M.J., Zhang, Z., Jones, R.A., and Miller, S.I. (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436: 1171-1175.
63. Hottes, A.K., Freddolino, P.L., Khare, A., Donnell, Z.N., Liu, J.C., and Tavazoie, S. (2013) Bacterial adaptation through loss of function. PLoS Genet 9: e1003617.
64. Hua, Q., Yang, C., Oshima, T., Mori, H., and Shimizu, K. (2004) Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat cultures. Appl Environ Microbiol 70: 2354-2366.
65. Illarramendi, X., del Rey de Oliveira, M.L.W., Sales, A.M., da Costa Nery, J.A., and Sarno, E.N. (2013) Considerations on clinical trials of leprosy treatment: need of novel drug combinations. Clin Investig 3: 617-635.
66. Jawetz, E. (1968) The use of combinations of antimicrobial drugs. Annu Rev Pharmacol 8: 151-170.
67. Jerman, B., Butala, M., and Žgur-Bertok, D. (2005) Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli. Antimicrob Agents Chemother 49: 3087-3090.
68. Keren, I., Wu, Y., Inocencio, J., Mulcahy, L.R., and Lewis, K. (2013a) Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339: 1213-1216.
69. Keren, L., Zackay, O., Lotan-Pompan, M., Barenholz, U., Dekel, E., Sasson, V., etal. (2013b) Promoters maintain their relative activity levels under different growth conditions. Mol Syst Biol 9: 701.
70. Keseler, I.M., Collado-Vides, J., Santos-Zavaleta, A., Peralta-Gil, M., Gama-Castro, S., Muñiz-Rascado, L., etal. (2011) EcoCyc: a comprehensive database of Escherichia coli biology. Nucleic Acids Res 39: D583-D590.
71. Khan, S.R., and Yamazaki, H. (1972) Trimethoprim-induced accumulation of guanosine tetraphosphate (ppGpp) in Escherichia coli. Biochem Biophys Res Commun 48: 169-174.
72. Khil, P.P., and Camerini-Otero, R.D. (2002) Over 1000 genes are involved in the DNA damage response of Escherichia coli. Mol Microbiol 44: 89-105.
73. Klumpp, S., and Hwa, T. (2008) Growth-rate-dependent partitioning of RNA polymerases in bacteria. Proc Natl Acad Sci USA 105: 20245-20250.
74. Klumpp, S., Zhang, Z., and Hwa, T. (2009) Growth rate-dependent global effects on gene expression in bacteria. Cell 139: 1366-1375.
75. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A., and Collins, J.J. (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810.
76. Kohanski, M.A., Dwyer, D.J., and Collins, J.J. (2010) How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8: 423-435.
77. Kwon, Y.K., Higgins, M.B., and Rabinowitz, J.D. (2010) Antifolate-induced depletion of intracellular glycine and purines inhibits thymineless death in E.coli. ACS Chem Biol 5: 787-795.
78. Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., etal. (2013) Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol 9: 700.
79. Lee, H.H., Molla, M.N., Cantor, C.R., and Collins, J.J. (2010) Bacterial charity work leads to population-wide resistance. Nature 467: 82-85.
80. Lehár, J., Zimmermann, G.R., Krueger, A.S., Molnar, R.A., Ledell, J.T., Heilbut, A.M., etal. (2007) Chemical combination effects predict connectivity in biological systems. Mol Syst Biol 3: 80.
81. Lewin, C.S., and Amyes, S.G.B. (1991) The role of the SOS response in bacteria exposed to zidovudine or trimethoprim. J Med Microbiol 34: 329-332.
82. Lin, J.T., Connelly, M.B., Amolo, C., Otani, S., and Yaver, D.S. (2005) Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis. Antimicrob Agents Chemother 49: 1915-1926.
83. Liu, Y., and Imlay, J.A. (2013) Cell death from antibiotics without the involvement of reactive oxygen species. Science 339: 1210-1213.
84. Loewe, S. (1928) Die quantitativen Probleme der Pharmakologie. Ergeb Physiol 27: 47-187.
85. Lorian, V. (1975) Some effects of subinhibitory concentrations of antibiotics on bacteria. Bull N Y Acad Med 51: 1046-1055.
86. McCarty, J.M., Richard, G., Huck, W., Tucker, R.M., Tosiello, R.L., Shan, M., etal. (1999) A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 106: 292-299.
87. Mackay, M.L., Milne, K., and Gould, I.M. (2000) Comparison of methods for assessing synergic antibiotic interactions. Int J Antimicrob Agents 15: 125-129.
88. Madan Babu, M., Teichmann, S.A., and Aravind, L. (2006) Evolutionary dynamics of prokaryotic transcriptional regulatory networks. J Mol Biol 358: 614-633.
89. Maier, T., Schmidt, A., Güell, M., Kühner, S., Gavin, A.C., Aebersold, R., and Serrano, L. (2011) Quantification of mRNA and protein and integration with protein turnover in a bacterium. Mol Syst Biol 7: 511.
90. Michel, J.B., Yeh, P.J., Chait, R., Moellering, R.C., and Kishony, R. (2008) Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci USA 105: 14918-14923.
91. Moellering, R.C., Korzeniowski, O.M., Sande, M.A., and Wennersten, C.B. (1979) Species-specific resistance to antimicrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis 140: 203-208.
92. Nichols, R.J., Sen, S., Choo, Y.J., Beltrao, P., Zietek, M., Chaba, R., etal. (2011) Phenotypic landscape of a bacterial cell. Cell 144: 143-156.
93. Nikaido, H., and Vaara, M. (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49: 1-32.
94. Norrby, S.R., Nord, C.E., and Finch, R. (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5: 115-119.
95. Okumus, B., Yildiz, S., and Toprak, E. (2014) Fluidic and microfluidic tools for quantitative systems biology. Curr Opin Biotechnol 25: 30-38.
96. Peña-Miller, R., Lähnemann, D., Schulenburg, H., Ackermann, M., and Beardmore, R. (2012) The optimal deployment of synergistic antibiotics: a control-theoretic approach. J R Soc Interface 9: 2488-2502.
97. Peña-Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernandez, A., Rosenstiel, P., Schulenburg, H., and Beardmore, R. (2013) When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLoS Biol 11: e1001540.
98. Pillai, S.K., Moellering, R.C., Jr, and Eliopoulos, G.M. (2005) Antimicrobial combinations. In Antibiotics in Laboratory Medicine. Lorian, V. (ed.). Philadelphia, USA: Lippincott Williams & Wilkins, pp. 365-380.
99. Plotz, P.H., and Davis, B.D. (1962) Synergism between streptomycin and penicillin: a proposed mechanism. Science 135: 1067-1068.
100. Poelwijk, F.J., de Vos, M.G.J., and Tans, S.J. (2011) Tradeoffs and optimality in the evolution of gene regulation. Cell 146: 462-470.
101. Potrykus, K., and Cashel, M. (2008) (p)ppGpp: still magical?*. Annu Rev Microbiol 62: 35-51.
102. Price, C.T.D., Lee, I.R., and Gustafson, J.E. (2000) The effects of salicylate on bacteria. Int J Biochem Cell Biol 32: 1029-1043.
103. Price, M.N., Deutschbauer, A.M., Skerker, J.M., Wetmore, K.M., Ruths, T., Mar, J.S., etal. (2013) Indirect and suboptimal control of gene expression is widespread in bacteria. Mol Syst Biol 9: 660.
104. Rahal, J.J., and Simberkoff, M.S. (1979) Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens. Antimicrob Agents Chemother 16: 13-18.
105. Romero, D., Traxler, M.F., López, D., and Kolter, R. (2011) Antibiotics as signal molecules. Chem Rev 111: 5492-5505.
106. Rosner, J.L. (1985) Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. Proc Natl Acad Sci USA 82: 8771-8774.
107. Sánchez Navarro, A. (2005) New formulations of amoxicillin/clavulanic acid. Clin Pharmacokinet 44: 1097-1115.
108. Sangurdekar, D.P., Zhang, Z., and Khodursky, A.B. (2011) The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim. BMC Genomics 12: 583.
109. Sat, B., Hazan, R., Fisher, T., Khaner, H., Glaser, G., and Engelberg-Kulka, H. (2001) Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality. J Bacteriol 183: 2041-2045.
110. Scott, M., Gunderson, C.W., Mateescu, E.M., Zhang, Z., and Hwa, T. (2010) Interdependence of cell growth and gene expression: origins and consequences. Science 330: 1099-1102.
111. Segre, D., DeLuna, A., Church, G.M., and Kishony, R. (2005) Modular epistasis in yeast metabolism. Nat Genet 37: 77-83.
112. Shaw, K.J., Miller, N., Liu, X., Lerner, D., Wan, J., Bittner, A., and Morrow, B.J. (2003) Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J Mol Microbiol Biotechnol 5: 105-122.
113. Simmons, L.A., Foti, J.J., Cohen, S.E., and Walker, G.C. (2008) The SOS regulatory network. EcoSal Plus 2008. doi:10.1128/ecosalplus.5.4.3.
114. Skindersoe, M.E., Alhede, M., Phipps, R., Yang, L., Jensen, P.O., Rasmussen, T.B., etal. (2008) Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52: 3648-3663.
115. Tan, C., Smith, R.P., Srimani, J.K., Riccione, K.A., Prasada, S., Kuehn, M., and You, L. (2012) The inoculum effect and band-pass bacterial response to periodic antibiotic treatment. Mol Syst Biol 8: 617.
116. Taniguchi, Y., Choi, P.J., Li, G.W., Chen, H., Babu, M., Hearn, J., etal. (2010) Quantifying E.coli proteome and transcriptome with single-molecule sensitivity in single cells. Science 329: 533-538.
117. Toprak, E., Veres, A., Michel, J.B., Chait, R., Hartl, D.L., and Kishony, R. (2012) Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 44: 101-105.
118. Tuomanen, E., Cozens, R., Tosch, W., Zak, O., and Tomasz, A. (1986) The rate of killing of Escherichia coli by β-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol 132: 1297-1304.
119. Veening, J.W., Smits, W.K., and Kuipers, O.P. (2008) Bistability, epigenetics, and bet-hedging in bacteria. Annu Rev Microbiol 62: 193-210.
120. Vega, N.M., Allison, K.R., Samuels, A.N., Klempner, M.S., and Collins, J.J. (2013) Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci USA 110: 14420-14425.
121. Walsh, C. (2003) Antibiotics: Actions, Origins, Resistance, 1st edn. Washington, DC, USA: ASM Press.
122. Wei, J.R., Krishnamoorthy, V., Murphy, K., Kim, J.H., Schnappinger, D., Alber, T., etal. (2011) Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci USA 108: 4176-4181.
123. Weinstein, R.J., Young, L.S., and Hewitt, W.L. (1975) Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia. J Lab Clin Med 86: 853-862.
124. Wood, K., Nishida, S., Sontag, E.D., and Cluzel, P. (2012) Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci USA 109: 12254-12259.
125. Wood, K.B., and Cluzel, P. (2012) Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E.coli. BMC Syst Biol 6: 48.
126. Wood, K.B., Wood, K.C., Nishida, S., and Cluzel, P. (2014) Uncovering scaling laws to infer multidrug response of resistant microbes and cancer cells. Cell Rep 6: 1073-1084.
127. Worthington, R.J., and Melander, C. (2013) Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol 31: 177-184.
128. Yeh, P., Tschumi, A.I., and Kishony, R. (2006) Functional classification of drugs by properties of their pairwise interactions. Nat Genet 38: 489-494.
129. Yeh, P.J., Hegreness, M.J., Aiden, A.P., and Kishony, R. (2009) Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7: 460-466.
130. Yim, G., Huimi Wang, H., and Davies, J. (2007) Antibiotics as signalling molecules. Philos Trans R Soc Lond B Biol Sci 362: 1195-1200.
131. Yonath, A. (2005) Antibiotics targeting ribosomes: resistance, selectivity, synergism, and cellular regulation. Annu Rev Biochem 74: 649-679.
132. Young, J.W., Locke, J.C.W., Altinok, A., Rosenfeld, N., Bacarian, T., Swain, P.S., etal. (2012) Measuring single-cell gene expression dynamics in bacteria using fluorescence time-lapse microscopy. Nat Protoc 7: 80-88.
133. Zaslaver, A., Bren, A., Ronen, M., Itzkovitz, S., Kikoin, I., Shavit, S., etal. (2006) A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods 3: 623-628.
134. Zimmermann, G.R., Lehár, J., and Keith, C.T. (2007) Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12: 34-42.